Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Robeauté raises $28 million for neurosurgical microrobots to transform brain health

Jan 15, 2025•over 1 year ago

Contract Type

partnership

ParisBiotechnologyHealth CareMedicalMedical Device

Description

Robeauté, a medtech startup, has raised 28 million USD led by Plural, Cherry Ventures, and Kindred Ventures. The funding will be used to continue developing the technology, starting human trials in 2026, and setting up US operations ahead of FDA approval and full go-to-market.

Company Information

Company

Robeauté

Location

Paris, Ile De France, France

About

Robeauté is a Paris-based startup focused on developing self-propelled microrobots designed to operate within the human brain. Their primary goal is to assist neurosurgeons in procedures such as tissue sample collection for biopsies. The company aims to enable targeted delivery of cancer treatments and other therapeutic applications for various brain disorders. Founded in 2017, Robeauté combines advanced robotics with medical needs to create groundbreaking solutions in neurosurgery.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Robeauté's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months